Sipjeondaebo-tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy

Tohoku Journal of Experimental Medicine

Volumn 234, Issue 3, 2014, Pages 229-236

  Lee, Yun Mi ^a   Kim, Chan Sik ^a   Sohn, Eunjin ^a   Jo, Kyuhyung ^a   Lim, Hye Ryeng ^a   Kim, Sun Ki ^a   Kim, Jin Sook ^a   Kim, Junghyun ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Oxygen induced retinopathy; Platelet derived growth factor; Retinal neovascularization; Sipjeondaebo tang; Vascular endothelial growth factor

Indexed keywords

ANGELICA GIGAS EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; ATRACTYLODES JAPONICA EXTRACT; CINNAMOMUM CASSIA EXTRACT; CNIDIUM OFFICINALE EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HERBACEOUS AGENT; JUJUBE EXTRACT; MESSENGER RNA; OXYGEN; PAEONIA LACTIFLORA EXTRACT; PLANT EXTRACT; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PORIA COCOS EXTRACT; REHMANNIA GLUTINOSA EXTRACT; SIPJEONDAEBO TANG; UNCLASSIFIED DRUG; VASCULOTROPIN; JUZENTAIHOTO; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; PROTEIN BINDING; VASCULOTROPIN A;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; ATRACTYLODES; ATRACTYLODES JAPONICA; CNIDIUM; CNIDIUM OFFICINALE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; IC50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE MODEL; NEWBORN; NONHUMAN; OXYGEN-INDUCED RETINOPATHY; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; TREATMENT DURATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; RETINAL NEOVASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; HUMANS; MICE, INBRED C57BL; OXYGEN; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-SIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RETINAL NEOVASCULARIZATION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84916224424     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.234.229     Document Type: Article

References (38)

1. Aiello, L.P. (1997) Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic. Res., 29, 354-362.
2. Aiello, L.P., Avery, R.L., Arrigg, P.G., Keyt, B.A., Jampel, H.D., Shah, S.T., Pasquale, L.R., Thieme, H., Iwamoto, M.A., Park, J.E., Nguyen, H.V., Aiello, L.M., Ferrara, N. & King, G.L. (1994) Vascular endothelial growth factor in ocular fuid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med., 331, 1480-1487.
3. Alvarez, R.H., Kantarjian, H.M. & Cortes, J.E. (2006) Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin. Proc., 81, 1241-1257.
4. Appelmann, I., Liersch, R., Kessler, T., Mesters, R.M. & Berdel, W.E. (2010) Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothe-lial growth factor (VEGF) and their receptors: biological functions and role in malignancy. Recent Results Cancer Res., 180, 51-81.
5. Benjamin, L.E., Hemo, I. & Keshet, E. (1998) A plasticity window for blood vessel remodelling is defned by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development, 125, 1591-1598.
6. Butchbach, M.E., Edwards, J.D., Schussler, K.R. & Burghes, A.H. (2007) A novel method for oral delivery of drug compounds to the neonatal SMNDelta7 mouse model of spinal muscular atrophy. J. Neurosci. Methods, 161, 285-290.
7. Campochiaro, P.A. (2013) Ocular neovascularization. J. Mol. Med. (Berl), 91, 311-321.
8. Cao, L., Liu, H., Lam, D.S., Yam, G.H. & Pang, C.P. (2010) In vitro screening for angiostatic potential of herbal chemicals. Invest. Ophthalmol. Vis. Sci., 51, 6658-6664.
9. Castellon, R., Hamdi, H.K., Sacerio, I., Aoki, A.M., Kenney, M.C. & Ljubimov, A.V. (2002) Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp. Eye Res., 74, 523-535.
10. Giddabasappa, A., Eswaraka, J.R., Barrett, C.M., Bauler, M.N., Wu, Z., Yepuru, M., Miller, D.D. & Dalton, J.T. (2012) β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization. Invest. Ophthalmol. Vis. Sci., 53, 5066-5075.
11. Haranaka, K., Satomi, N., Sakurai, A., Haranaka, R., Okada, N. & Kobayashi, M. (1985) Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol. Immunother., 20, 1-5.
12. Heldin, C.H., Ostman, A. & Ronnstrand, L. (1998) Signal trans-duction via platelet-derived growth factor receptors. Biochim. Biophys. Acta, 1378, F79-113.
13. Heldin, C.H. & Westermark, B. (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev., 79, 1283-1316.
14. Hsiu, S.L., Lin, Y.T., Wen, K.C., Hou, Y.C. & Chao, P.D. (2003) A deglucosylated metabolite of paeoniflorin of the root of Paeonia lactiflora and its pharmacokinetics in rats. Planta Med., 69, 1113-1118.
15. Hua, J., Guerin, K.I., Chen, J., Michan, S., Stahl, A., Krah, N.M., Seaward, M.R., Dennison, R.J., Juan, A.M., Hatton, C.J., Sapieha, P., Sinclair, D.A. & Smith, L.E. (2011) Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. Invest. Ophthalmol. Vis. Sci., 52, 2809-2816.
16. Ji, B., Geng, P., Liu, J.G., Shi, D.Z. & Wang, Y.Y. (2006) Effects of active components extracted from Qixue Bingzhi Recipe on proliferation of vascular smooth muscle cells and expressions of platelet-derived growth factor and its receptor genes. Zhong Xi Yi Jie He Xue Bao, 4, 30-34.
17. Kamiyama, H., Takano, S., Ishikawa, E., Tsuboi, K. & Matsumura, A. (2005) Anti-angiogenic and immunomodulatory effect of the herbal medicine “Juzen-taiho-to” on malignant glioma. Biol. Pharm. Bull., 28, 2111-2116.
18. Kim, K.J., Choi, J.S., Kim, K.W. & Jeong, J.W. (2013) The anti-angiogenic activities of glycyrrhizic acid in tumor progression. Phytother. Res., 27, 841-846.
19. Kiyohara, H., Matsumoto, T. & Yamada, H. (2004) Combination Effects of Herbs in a Multi-herbal Formula: Expression of Juzen-taiho-to’s Immuno-modulatory Activity on the Intestinal Immune System. Evid. Based Complement. Alternat. Med., 1, 83-91.
20. Kociok, N., Radetzky, S., Krohne, T.U., Gavranic, C. & Joussen, A.M. (2006) Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-defcient mice. Invest. Ophthalmol. Vis. Sci., 47, 5057-5065.
21. Kogure, T., Hoshino, A., Ito, K., Sato, H., Tatsumi, T., Ohyama, Y., Kawata, E., Fujita, K. & Tamura, J. (2005) Benefcial effect of complementary alternative medicine on lymphedema with rheumatoid arthritis. Mod. Rheumatol., 15, 445-449.
22. Kumar Gupta, S., Kumar, B., Srinivasan, B.P., Nag, T.C., Srivastava, S., Saxena, R. & Aggarwal, A. (2013) Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats. J. Ocul. Pharmacol. Ther., 29, 419-426.
23. Lee, J.J., Hsiao, C.C., Yang, I.H., Chou, M.H., Wu, C.L., Wei, Y.C., Chen, C.H. & Chuang, J.H. (2012) High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5. Mol. Vis., 18, 838-850.
24. Lee, Y.M., Kim, J., Jo, K., Shin, S.D., Kim, C.S., Sohn, E.J., Kim, S.G. & Kim, J.S. (2013) Ethyl pyruvate inhibits retinal pathogenic neovascularization by downregulating HMGB1 expression. J. Diabetes Res., 2013, 245-271.
25. Lee, H.J., Lee, E.O., Rhee, Y.H., Ahn, K.S., Li, G.X., Jiang, C., Lu, J. & Kim, S.H. (2006) An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogen-esis, apoptosis and metastasis. Carcinogenesis, 27, 2455-2463.
26. McClain, R.M., Keller, D., Casciano, D., Fu, P., MacDonald, J., Popp, J. & Sagartz, J. (2001) Neonatal mouse model: review of methods and results. Toxicol. Pathol., 29 Suppl, 128-137.
27. Miki, K., Miki, A., Matsuoka, M., Muramatsu, D., Hackett, S.F. & Campochiaro, P.A. (2009) Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor. Ophthalmology, 116, 1748-1754.
28. Raines, E.W. (2004) PDGF and cardiovascular disease. Cytokine Growth Factor Rev., 15, 237-254.
29. Ross, R., Glomset, J., Kariya, B. & Harker, L. (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA, 71, 1207-1210.
30. Ruma, I.M., Putranto, E.W., Kondo, E., Watanabe, R., Saito, K., Inoue, Y., Yamamoto, K., Nakata, S., Kaihata, M., Murata, H. & Sakaguchi, M. (2014) Extract of Cordyceps militaris inhibits angiogenesis and suppresses tumor growth of human malignant melanoma cells. Int. J. Oncol., 45, 209-218.
31. Shin, I.S., Yu, Y.B., Seo, C.S., Ha, H.K., Lee, M.Y., Huang, D.S., Kim, J.H. & Shin, H.K. (2011) Subchronic toxicity of Sipjeondaebo-tang (SDT) in Sprague-Dawley rats. Regul. Toxicol. Pharmacol., 59, 375-384.
32. Tagami, K., Niwa, K., Lian, Z., Gao, J., Mori, H. & Tamaya, T. (2004) Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol. Pharm. Bull., 27, 156-161.
33. Tanaka, J., Nakamura, S., Tsuruma, K., Shimazawa, M., Shimoda, H. & Hara, H. (2012) Purple rice (Oryza sativa L.) extract and its constituents inhibit VEGF-induced angiogenesis. Phyto-ther. Res., 26, 214-222.
34. Vassbotn, F.S., Havnen, O.K., Heldin, C.H. & Holmsen, H. (1994) Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J. Biol. Chem., 269, 13874-13879.
35. Wankun, X., Wenzhen, Y., Min, Z., Weiyan, Z., Huan, C., Wei, D., Lvzhen, H., Xu, Y. & Xiaoxin, L. (2011) Protective effect of paeoniforin against oxidative stress in human retinal pigment epithelium in vitro. Mol. Vis., 17, 3512-3522.
36. Yance, D.R. Jr. & Sagar, S.M. (2006) Targeting angiogenesis with integrative cancer therapies. Integr. Cancer Ther., 5, 9-29.
37. Zehetner, C., Kirchmair, R., Neururer, S.B., Kralinger, M.T., Bechrakis, N.E. & Kieselbach, G.F. (2014) Systemic upregu-lation of PDGF-B in patients with neovascular AMD. Invest. Ophthalmol. Vis. Sci., 55, 337-344.
38. Zheng, Y.Q., Wei, W., Zhu, L. & Liu, J.X. (2007) Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats. Infamm. Res., 56, 182-188.